Ascendis Pharma A/S (ASND) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and argenx (NASDAQ:ARGX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.

Which has stronger valuation and earnings, ASND or ARGX?

argenx has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$363.64M	25.05	-$409.12M	-$7.10	-21.14
argenx	$2.19B	16.37	-$295.05M	$12.59	46.87

Which has more volatility & risk, ASND or ARGX?

Ascendis Pharma A/S has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Does the media favor ASND or ARGX?

In the previous week, Ascendis Pharma A/S had 3 more articles in the media than argenx. MarketBeat recorded 13 mentions for Ascendis Pharma A/S and 10 mentions for argenx. argenx's average media sentiment score of 1.54 beat Ascendis Pharma A/S's score of 1.37 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	10 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
argenx	9 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is ASND or ARGX more profitable?

argenx has a net margin of -2.11% compared to Ascendis Pharma A/S's net margin of -104.54%. Ascendis Pharma A/S's return on equity of 0.00% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-104.54%	N/A	-39.23%
argenx	-2.11%	-1.45%	-1.29%

Does the MarketBeat Community believe in ASND or ARGX?

argenx received 207 more outperform votes than Ascendis Pharma A/S when rated by MarketBeat users. Likewise, 67.28% of users gave argenx an outperform vote while only 66.82% of users gave Ascendis Pharma A/S an outperform vote.

Company	Underperform	Outperform
Ascendis Pharma A/S	Outperform Votes 447 66.82%	Underperform Votes 222 33.18%
argenx	Outperform Votes 654 67.28%	Underperform Votes 318 32.72%

Do analysts recommend ASND or ARGX?

Ascendis Pharma A/S currently has a consensus target price of $204.64, suggesting a potential upside of 36.35%. argenx has a consensus target price of $687.00, suggesting a potential upside of 16.43%. Given Ascendis Pharma A/S's stronger consensus rating and higher probable upside, equities analysts clearly believe Ascendis Pharma A/S is more favorable than argenx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.93
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91

Do institutionals and insiders hold more shares of ASND or ARGX?

60.3% of argenx shares are held by institutional investors. 40.0% of Ascendis Pharma A/S shares are held by insiders. Comparatively, 2.4% of argenx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

argenx beats Ascendis Pharma A/S on 11 of the 19 factors compared between the two stocks.